Genetic and molecular factors in myocardial fibrosis

Description of the granted funding

Cardiovascular diseases are globally among the leading causes of mortality. Myocardial fibrosis means accumulation of excess of extracellular matrix in the heart. After myocardial infarction cardiomyocytes die and fibrotic scar is formed to protect the integrity of the heart. Accumulation of excess of fibrotic tissue can also be a response to for example ageing or obesity. Fibrosis increases cardiac tissue stiffness leading to impaired heart function and predisposes to sudden cardiac death. In this research, I will identify new genetic factors leading to myocardial fibrosis and sudden cardiac death in a unique data set of 228 sudden cardiac death victims. I will also investigate the role of miRNA editing, a regulatory mechanism for gene expression, in cardiac fibrosis using patient samples and cell models. Furthermore, I investigate if diagnosis of fibrosis and prediction of sudden cardiac death could be improved by using miRNAs as biomarkers.
Show more

Starting year

2022

End year

2026

Granted funding

Sini Skarp Orcid -palvelun logo
245 296 €

Funder

Research Council of Finland

Funding instrument

Postdoctoral Researcher

Decision maker

Scientific Council for Biosciences, Health and the Environment
28.04.2022

Other information

Funding decision number

349331

Fields of science

Biomedicine

Research fields

Biolääketieteet

Identified topics

cardiovascular diseases